3,044
Views
3
CrossRef citations to date
0
Altmetric
Introduction

The neurotechnology and society interface: responsible innovation in an international context

, , &
Pages 1-12 | Received 17 Aug 2017, Accepted 25 Sep 2017, Published online: 05 Mar 2018

References

  • Abrams, R. 1979. “The ECT Controversy: Some Observations and a Suggestion.” Psychiatric Opinion 16: 11–15.
  • Aicardi, C., M. Reinsborough, and N. Rose. 2017. “The Integrated Ethics and Society Programme of the Human Brain Project: Reflecting on an Ongoing Experience.” Journal of Responsible Innovation 5 (1): 13–37.
  • Alzheimer’s Disease International. 2016. World Alzheimer Report 2016. https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf.
  • Amunts, K., C. Ebell, J. Muller, M. Telefont, A. Knoll, and T. Lippert. 2016. “The Human Brain Project: Creating a European Research Infrastructure to Decode the Human Brain.” Neuron 92: 574–581. doi: 10.1016/j.neuron.2016.10.046
  • Australian Academy of Science. 2016. Why Australia Needs a Brain Initiative. Accessed July 12, 2017. https://www.science.org.au/supporting-science/other-initiatives/ausbrain/why-australia-needs-brain-initiative.
  • Blok, V. 2014. “Look Who’s Talking: Responsible Innovation, the Paradox of Dialogue and the Voice of the Other in Communication and Negotiation Processes.” Journal of Responsible Innovation 1 (2): 171–190. doi: 10.1080/23299460.2014.924239
  • Bloom, D. E., E. T. Caero, E. Jané-Llopis, S. Abrahams-Gessel, L. R. Bloom, S. Fathima, A. B. Feigl, et al. 2011. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum.
  • Christie, G. 2017. Progressing the Health Agenda: Responsibly Innovating in Health Technology. Journal of Responsible Innovation 5 (1): 143–148.
  • Coccaro, E. F., and L. J. Siever. 1985. “Second Generation Antidepressants: A Comparative Review.” The Journal of Clinical Pharmacology 25 (4): 241–260. doi: 10.1002/j.1552-4604.1985.tb02835.x
  • Finger, S. 2001. Origins of Neuroscience: A History of Explorations Into Brain Function. Oxford: Oxford University Press.
  • Fisher, E., M. O’Rourke, R. Evans, E. B. Kennedy, M. E. Gorman, and T. P. Seager. 2015. “Mapping the Integrative Field: Taking Stock of Socio-technical Collaborations.” Journal of Responsible Innovation 2 (1): 39–61. doi: 10.1080/23299460.2014.1001671
  • Garden, H., D. M. Bowman, S. Haesler, and D. E. Winickoff. 2016. “Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science.” Neuron 92 (3): 642–646. doi: 10.1016/j.neuron.2016.10.053
  • Greely, H. T., K. M. Ramos, and C. Grady. 2016. “Neuroethics in the Age of Brain Projects.” Neuron 92 (3): 637–641. doi: 10.1016/j.neuron.2016.10.048
  • Grillner, S., N. Ip, C. Koch, W. Koroshetz, H. Okano, M. Polachek, M. Poo, and T. J. Sejnowski. 2016. “Worldwide Initiatives to Advance Brain Research.” Nature Neuroscience 19 (9): 1118–1122. doi: 10.1038/nn.4371
  • Gross, C. G. 1999. Brain, Vision, Memory: Tales in the History of Neuroscience. Cambridge: MIT Press.
  • Guston, D. H. 2014. “Understanding ‘Anticipatory Governance’.” Social Studies of Science 44 (2): 218–242. doi: 10.1177/0306312713508669
  • Hauser, S. L. 2014. “What Ethics Integration Looks Like in Neuroscience Research.” Annals of Neurology 75 (5): 623–624. doi: 10.1002/ana.24177
  • Insel, T. R., P. Y. Collins, and S. E. Hyman. 2015. “Darkness Invisible: The Hidden Global Costs of Mental Illness.” Foreign Affairs 94: 127–135.
  • Institute for Health Metrics and Evaluation (IHME). 2016. Rethinking Development and Health: Findings From the Global Burden of Disease Study. Seattle: IHME.
  • Ioannidis, J. P. 2008. “Effectiveness of Antidepressants: An Evidence Myth Constructed From a Thousand Randomized Trials?” Philosophy, Ethics, and Humanities in Medicine 3 (1): 14–22. doi: 10.1186/1747-5341-3-14
  • Jeong, S. J., H. Lee, E. M. Hur, Y. Choe, J. W. Koo, J. C. Rah, K. J. Lee, et al. 2016. “Korea Brain Initiative: Integration and Control of Brain Functions.” Neuron 92 (3): 607–611. doi: 10.1016/j.neuron.2016.10.055
  • Johnson, J. 2009. “A Dark History: Memories of Lobotomy in the new era of Psychosurgery.” Medicine Studies 1 (4): 367–378. doi: 10.1007/s12376-009-0031-7
  • Judd, L. L. 1998. “A Decade of Antidepressant Development: The SSRIs and Beyond.” Journal of Affective Disorders 51 (3): 211–213. doi: 10.1016/S0165-0327(98)00220-1
  • Jwa, A. 2017. DIY tDCS: A Need for An Empirical Look. Journal of Responsible Innovation 5 (1): 103–108.
  • Kucharski, A. 1984. “History of Frontal Lobotomy in the United States, 1935–1955.” Neurosurgery 14 (6): 765–772. doi: 10.1227/00006123-198406000-00022
  • Lauber, C., C. Nordt, L. Falcato, and W. Rössler. 2005. “Can a Seizure Help? The Public’s Attitude Toward Electroconvulsive Therapy.” Psychiatry Research 134 (2): 205–209. doi: 10.1016/j.psychres.2004.07.010
  • Lenzer, J. 2004. “FDA Hearings Confirm Risks of Antidepressants.” British Medical Journal 329 (7467): 641. doi: 10.1136/bmj.329.7467.641
  • Martin, C. L., and M. Chun. 2016. “The BRAIN Initiative: Building, Strengthening, and Sustaining.” Neuron 92 (3): 570–573. doi: 10.1016/j.neuron.2016.10.039
  • McGurrin, P., and E. K. Frow. 2017. Governing Citizen Use of Brain Stimulation Technologies: What Role for Scientists? Journal of Responsible Innovation 5 (1): 117–121.
  • Mukherjee, S., H. A. Sackeim, and D. B. Schnur. 1994. “Electroconvulsive Therapy of Acute Manic Episodes: A Review of 50 Years’“ Experience.” American Journal of Psychiatry 151 (2): 169–176. doi: 10.1176/ajp.151.2.169
  • National Institutes of Health. 1985. Electro-convulsive Therapy (Vol. 5, No. 11). Washington, DC: US Dept. of Health and Human Services, National Institutes of Health, Office of Medical Applications of Research.
  • Nowak, R., and E. Paton. 2017. SWOT Analysis of The Brain Dialogue, an Australian Prototype Responsible Research and Innovation Engagement Program for Neuroscience. Journal of Responsible Innovation 5 (1): 131–142.
  • Okano, H., E. Sasaki, T. Yamamori, A. Iriki, T. Shimogori, Y. Yamaguchi, K. Kasai, and A. Miyawaki. 2016. “Brain/MINDS: A Japanese National Brain Project for Marmoset Neuroscience.” Neuron 92 (3): 582–590. doi: 10.1016/j.neuron.2016.10.018
  • Organisation for Economic Co-operation and Development. 2016. Issues Paper: OECD Workshop “Neurotechnology and Society: Strengthening Responsible Innovation in Brain Science. Paris: OECD.
  • Organisation for Economic Co-operation and Development. 2017. The Next Production Revolution: Implications for Governments and Business. Paris: OECD Publishing. doi: 10.1787/9789264271036-en
  • Owen, R., J. Bessant, and M. Heintz, eds. 2013. Responsible Innovation: Managing the Responsible Emergence of Science and Innovation in Society. Hoboken, NJ: John Wiley & Sons.
  • Poo, M. M., J. L. Du, N. Y. Ip, Z. Q. Xiong, B. Xu, and T. Tan. 2016. “China Brain Project: Basic Neuroscience, Brain Diseases, and Brain-inspired Computing.” Neuron 92 (3): 591–596. doi: 10.1016/j.neuron.2016.10.050
  • Presidential Commission for the Study of Bioethical Issues. 2014. Gray Matters: Integrative Approaches for Neuroscience, Ethics, and Society. Washington, DC: Government Printing Office.
  • Ramos, K. M., K. S. Rommelfanger, H. T. Greely, and W. J. Koroshetz. 2017. Neuroethics and the NIH BRAIN Initiative. Journal of Responsible Innovation 5 (1): 122–130.
  • Reber, B. 2017. RRI as the Inheritor of Deliberative Democracy and the Precautionary Principle. Journal of Responsible Innovation 5 (1): 38–64.
  • Sapolsky, R. M. 2001. “Depression, Antidepressants, and the Shrinking Hippocampus.” Proceedings of the National Academy of Sciences 98 (22): 12320–12322. doi: 10.1073/pnas.231475998
  • Schwab, K. 2016. “The Fourth Industrial Revolution.” World Economic Forum. Accessed April 17, 2017. http://www3.weforum.org/docs/Media/KSC_4IR.pdf.
  • Schwartz, T. L. 2016. Second and Third Generation Antipsychotics: A Comprehensive Handbook. London: AuthorHouse.
  • Shelley-Egan, C., A. B. Hanssen, L. Landeweerd, and B. Hofmann. 2017. Responsible Research and Innovation in the Context of Human Cognitive Enhancement: Some Essential Features. Journal of Responsible Innovation 5 (1): 65–85.
  • Smith, C. D. 2017. The Electric Brain: Do-it-yourself Healthcare with Transcranial Direct Current Stimulation. Journal of Responsible Innovation 5 (1): 86–97.
  • Sullivan, L. S., and J. Illes. 2017. Models of Engagement in Neuroethics Programs: Past, Present, and Future. In Debates About Neuroethics. Advances in Neuroethics, edited by E. Racine, and J. Aspler. Cham: Springer.
  • United Kingdom ECT Review Group. 2003. “Efficacy and Safety of Electroconvulsive Therapy in Depressive Disorders: A Systematic Review and Meta-analysis.” The Lancet 361 (9360): 799–808. doi: 10.1016/S0140-6736(03)12705-5
  • Valenstein, E. S. 1986. Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness. New York: Basic Books.
  • White House Office of Science and Technology Policy. 2016. “Obama Administration Proposes Over $434 Million in Funding for the BRAIN Initiative.” March. Accessed April 18, 2017. https://www.whitehouse.gov/sites/whitehouse.gov/files/documents/BRAIN%20Initiative%20FY17%20Fact%20Sheet.pdf.
  • Yuste, R., and C. Bargmann. 2017. “Toward a Global BRAIN Initiative.” Cell 168. doi:10.1016/j.cell.2017.02.023.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.